Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need.

Headquartered in Foster City, California, the company has expanded rapidly over the past two decades, with annual revenues now exceeding $7 billion, operations spanning four continents and a staff of approximately 4,000 employees.

Gilead’s primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.